Cryogenic transmission electron microscopy confirmed the vesicular nature of the material pelleted out of plasma by ultracentrifugation ( Figure 1A inset; S u p p l e m e n t a l 2). FACS confirmed the near complete removal of MP ( Figure 1A ; >80% in SCD; p<0.01).
Interestingly, it was accompanied by a 38% reduction in plasma Hb ( Figure 1C ; p=0.042 in SCD 
Erythrocyte vesiculation in vitro
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We aimed to generate and describe stocks of purified erythrocyte MP that could be manipulated in cultures and in vivo. To induce vesiculation, we stimulated freshly sorted human SCD and control erythrocytes with the CD47 agonist peptide 4N1-1, a peptide derived from the thrombospondin-1 carboxyterminus 20, 38 . Cryo-transmission electron microscopy on supernatants revealed that erythrocytes released MP with a membrane and a size distribution compatible with native plasma. Erythrocytes released about 12-fold more MP when treated with 4N1-1 versus control peptides ( Figure 1E ; n=4, p<0.001). Spectrophotometry ( Figure   1F -G, n=3) determined that MP released by SCD erythrocytes contained twice more heme than control MP (p=0.038). In short, 50 control erythrocyte MP/μl carried about 20 nM heme, whereas 50 SCD erythrocyte MP/μl carried about 65 nM heme. Met-Hb represented a large part (45 to 75%) of Hb associated to erythrocyte MP (Supplemental 4). SCD MP displayed a trend of higher met-Hb contents, although not significant. We concluded that in vitro vesiculation concurred with Hb and heme release, resulting in met-Hb-and heme-laden MP.
Phospholipid vesicles concentrate heme
We aimed to generate synthetic phospholipid vesicles to mimic erythrocyte MP. Multilayer vesicles (MLV) or large unilamellar vesicles (LUV) prepared in vitro by phospholipid extrusion contained no detectable heme (Abs 398 ; Figure 2A ). However, MLV and LUV incubated in heme absorbed it (about 10 μg heme for 50,000 vesicles; n=3, p=0.033 and 0.031). Conversely, Hemopexin (Hpx, 10 μM for 2 hours) strongly reduced heme incorporation into MLV ( Figure 2B ; n=3, p<0.001), so did the detergents triton and saponin (0.1 to 5% ; p<0.001 vs. none).
Erythrocyte MP generated in vitro (5000 PS+ MP/100 μl) were also treated with Hpx, triton or saponin, or a mixture of EDTA and EGTA. MP were ultracentrifuged and resuspended for a spectrophotometric evaluation of heme ( Figure 2C ). Triton (5%) and saponin (1%) reduced heme:MP association by up to 50% (n=3, p<0.05 for both). Interestingly, Hpx reduced heme:MP association by 20% in control MP and 50% in SCD MP (p=0.022 and p=0.035; Figure 2D ). Removal of Ca 2+ with EDTA/EGTA reduced heme by about 50% in WT and SCD MP (p=0.077 and p=0.040; Figure 2D ). This led us to hypothesize that PS and Ca 2+ might contribute to heme segregation in MP.
In silico modeling of molecular interactions predicted that one heme molecule is capable of binding to one PS via two Ca 2+ bonds. This is supported by calculation of interaction energies in a 3-dimension representation, and by dynamic modeling of heme interacting with one PS embedded in a phosphatidylcholine and cholesterol membrane (Supplemental 5A-B).
Heme-laden MP transfer heme to endothelial cells
We investigated the interaction of heme-laden MP with vascular endothelium as a possible target tissue to bind to and activate. We incubated cultured human umbilical cord vascular endothelial monolayers (HUVEC) with erythrocyte MP (50 PS+ MP/μl, 1 hour) and quantified heme transferred to HUVEC monolayers after washing ( Figure 3A ). Control erythrocyte MP transferred heme to HUVEC (n=6, p=0.047 vs. none), but MP from SCD erythrocytes were 4-fold more efficient (p=0.014 vs. none). Heme transfer was completely blocked by pre-incubating MP with the PS antagonist annexin-a5 (10 g/ml), or hemescavenging Hpx (2 μ  for 1 hour (p=0.032 and p=0.042). We also placed synthetic hemeladen MLV on HUVEC (50 MLV/μl, Figure 3B ). MLV transferred heme to HUVEC (p<0.001). Again the incorporation of heme into HUVEC monolayers was sensitive to annexin-a5 and Hpx (n=3, p<0.05 vs. MLV alone).
Heme-laden MP trigger endothelial ROS production and apoptosis
We asked whether the transfer of heme to endothelial cells by MP may activate the cells. We quantified ROS production by cultured HUVEC incubated with erythrocyte MP or MLV for 1 hour, before adding H 2 DFF-DA for 30 minutes. SCD erythrocyte MP triggered significant ROS production at 2.5 MP/μl and above ( Figure 3C ; n=4-8, p<0.001 vs. none or control MP).
Control MP only induced moderate ROS production at 50 MP/μl.
We pre-incubated SCD erythrocyte MP with annexin-a5 or Hpx ( Figure 3D ), or HUVEC with NADPH oxidase inhibitors apocynin and DPI for 1 hour. DPI and annexin-a5 completely prevented ROS production, whereas Hpx reduced it by half (n=4-8, p<0.001 for all vs. MP alone). SCD and control MP placed alone in H 2 DFF-DA for 1 hour only generated minimal amounts of ROS ( Figure 3E ). Synthetic heme-laden MLV placed on HUVEC also stimulated ROS production versus MLV alone (n=3, p<0.001), in an Annexin-a5-and Hpx-sensitive fashion ( Figure 3F ).
We confirmed the production of ROS using Luminol (Supplemental 6A; n=6, p<0.001 vs. Fluorescence microscopy ( Figure 4D ) confirmed that SCD MP doubled apoptotic nuclei (n=9, p=0.044 vs. none; Figure 4E ). Annexin-a5 and Hpx completely blocked these effects (p=0.001 and p=0.01 vs. MP alone). Moreover, heme-laden MLV induced significant apoptosis versus MLV alone (p<0.001; Figure 4F ).
Heme-laden MP and mouse mesenteric vasodilation
We sought to establish the physiopathological significance of heme-laden MP in vivo and 
Heme-laden MP and mouse kidney vaso-occlusions
We proceeded to characterize the impact of heme-laden MP on kidney vaso-occlusions in mice and their association with kidney injury in patients.
In SAD mice, intravenous administration of SAD MP induced a sudden 25% increase in Figure 5E ). MP did not affect cardiac output or heart rate (Supplemental 7D-E).
Conversely, SAD MP pre-incubated with Hpx (1 μM) failed to modify blood flow velocity (p=0.72 vs MP alone) or histology.
Next, we studied the distribution of Hb and CD235a (Glycophorin-A) in human renal biopsies and peripheral tumorectomy samples by fluorescence and enzymatic immunohistochemistry.
In healthy peritumoral kidney, erythrocytes presented circular shapes, homogenous Hb-filled cytoplasm and strong CD235a+ cell-surfaces ( Figure 6A ). SCD erythrocytes presented distorted shapes with Hb-filled cytoplasm, but also sub-membrane concentrated Hb deposits and spotty CD-235a+ labeling (Figure 6B-E Hb-laden MP. Some Hb deposits clearly stained for CD235a, suggesting colocalization with erythrocyte membrane fragments ( Figure 6G ). The distribution of CD235a and Hb was however garbled in these deposits. In culture, heme-laden erythrocyte MP and MLV, but not naked vesicles, triggered significant endothelial ROS production and eventual apoptosis. Conversely, apocynin and NAC blocked both ROS production and endothelial apoptosis. This suggested that heme-laden MP are cytotoxic through oxidant activity, a conclusion compatible with our previous observation that ROS inhibitors block the effects of erythrocyte MP on endothelial-dependent microvascular dilation ex vivo 20 . Mouse mesenteric resistances arteries were perfused with PSS alone and initial diameters provided controls. Arterioles were then pre-constricted with phenylephrine and endotheliumdependent vasodilation was assessed in response to acetylcholine (ACH; 10-7 to 10-4 M).
Heme-laden MP : An opening for novel therapeutic approaches
Arterioles were washed, constricted again with phenylephrine, and perfused with either SAD erythrocyte MP (300 MP/μl), or heme (100 nM) at 75 mm Hg pressure and 20 µl/sec flow. 
